macro1 min
Lina Life以微小残留癌检测获癌症后续管理保险独家使用权
发布: · 来源: mk.co.kr
一句$话总结: Lina Life Insurance通过基于微小残留癌检测、持续监测癌症诊断后复发和转移的产品取得独家使用权，抢占后续管理保障市场。
广告
매일 5분 안에 핵심 뉴스
Lina Life Insurance正通过一款在癌症诊断后持续监测复发和转移可能性的保险产品抢占市场。该产品与微小残留癌检测相结合，重点在于确认治疗后可能残留的癌细胞信号，Lina Life也因此取得了独家使用权。以往癌症保险主要集中在支付诊断保险金，而此次产品的特点是将癌症幸存者的后续管理作为新的保障领域推向前台。随着保险公司关注诊断后的管理需求，包含复发和转移监测的保障竞争可能进一步扩大。来源: mk.co.kr
广告
11개 언어 자동 번역
Partner picks
Relevant partner links for this story
A lightweight commerce block designed to add monetization without breaking reading flow.
Coupang PartnersKR conversion
Good fit for Korea-based visitors ready to buy.
View offerAliExpressBudget picks
Works well for price-sensitive gadget and desk-tool traffic.
View offerAmazon AssociatesGlobal reach
Useful for books, work tools, and international shoppers.
View offerThis module may include affiliate links that earn a commission from qualifying purchases. 매크로시그널
Sponsored
Get notifications
Subscribe to our daily digest
广告
매일 5분 안에 핵심 뉴스
